✦ LIBER ✦

Interleukin-2 activated T cells (T-LAK) express CD16 antigen and are triggered to target cell lysis by bispecific antibody

✍ Scribed by Taizo Nitta; Motomi Nakata; Hideo Yagita; Ko Okumura

Publisher: Elsevier Science
Year: 1991
Tongue: English
Weight: 509 KB
Volume: 28
Category: Article
ISSN: 0165-2478
DOI: 10.1016/0165-2478(91)90124-s

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bispecific monoclonal antibodies directe

Bispecific monoclonal antibodies directed to CD16 and to a tumor-associated antigen induce target-cell lysis by resting NK cells and by a subset of NK clones

✍ Silvano Ferrini; Ignazia Prigione; Silvia Miotti; Ermanno Ciccone; Claudia Canto 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 French ⚖ 716 KB

Activation of Lyt-2+ T cells by antibodi

Activation of Lyt-2+ T cells by antibodies towards brain-associated antigens. I. Accessory cell requirement and role of Fc receptors in the induction of reactivity to interleukin 2

✍ Martin Gullberg; Sven R. Carlsson; Eva-Lotta Larsson 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 896 KB

Treatment of the P815 murine mastocytoma

Treatment of the P815 murine mastocytoma with cisplatin or etoposide up-regulates cell-surface Fas (CD95) expression and increases sensitivity to anti-Fas antibody-mediated cytotoxicity and to lysis by anti-CD3-activated killer-T cells

✍ Brent A. Williams; Andrew P. Makrigiannis; Jonathan Blay; David W. Hoskin 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 122 KB 👁 2 views

We have investigated the effect of pre-treatment with the anti-cancer drugs cisplatin and etoposide on the susceptibility of P815 murine mastocytoma cells to lysis by murine spleen-derived anti-CD3-activated killer-T (AK-T) cells. A 20 hr pre-treatment with cisplatin (0.2-2 microg/ml) or etoposide (